Development of New Products and Technologies and Improvement of Existing Products
First written in FY2016. 24 of 36 entries say "Restated". Latest entry: FY2026.
8 other companies' latest entry also says "Other".
- FY2026R&D expenses decreased year on yearAnnual report
「Total R&D expenses for the fiscal year were ¥333 million.」
R&D expenses fell from ¥393 million in the previous fiscal year to ¥333 million. The R&D objectives of developing new products and technologies and improving and applying existing products were maintained. - FY2026-H1R&D expenses decreased year on yearAnnual report
「The Group's total R&D spending for the six-month consolidated accounting period was ¥174 million.」
There were no material changes in the R&D policy, while R&D expenses fell from ¥220 million in the same period of the previous year to ¥174 million. - FY2025Research and development expenses increased year on yearAnnual report
「The Group's R&D activities include the development of new products and technologies, the improvement and enhancement of existing products, and their application. These activities are undertaken to research and develop products that meet increasingly diverse and sophisticated user needs. Total R&D expenses for the fiscal year were ¥393 million.」
The focus and objectives of R&D were maintained, while R&D expenses rose from ¥363 million in the previous fiscal year to ¥393 million. - FY2025-H1Research and development expenses increased year on yearAnnual report
「The Group's total R&D spending for the six-month consolidated accounting period was ¥220 million. There were no material changes in the status of the Group's R&D activities during the six-month consolidated accounting period.」
There were no material changes in the R&D policy, while R&D expenses rose to ¥220 million from ¥180 million in the same period of the previous year. - FY2024Research and development expenses increased year on yearAnnual report
「The Group's R&D activities include the development of new products and technologies, the improvement and enhancement of existing products, and their application. These activities are undertaken to research and develop products that meet increasingly diverse and sophisticated user needs. Total R&D expenses for the fiscal year were ¥363 million.」
The focus and objectives of R&D were maintained, while R&D expenses rose to ¥363 million from ¥356 million in the previous fiscal year. - FY2024-Q3R&D expenses decreased year on yearAnnual report
「The Group's total R&D spending for the nine-month consolidated cumulative period was ¥261 million. There were no material changes in the status of the Group's R&D activities during the nine-month consolidated cumulative period.」
There were no material changes in the R&D policy, while R&D expenses fell to ¥261 million from ¥271 million in the same period of the previous year. - FY2024-Q2R&D expenses decreased year on yearAnnual report
「The Group's total R&D spending for the six-month consolidated cumulative period was ¥166 million. There were no material changes in the status of the Group's R&D activities during the six-month consolidated cumulative period.」
There were no material changes in the R&D policy, while R&D expenses fell to ¥166 million from ¥180 million in the same period of the previous year. - FY2024-Q1RestatedAnnual report
「Group-wide research and development expenses for the first quarter of the consolidated fiscal year were ¥82 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the consolidated fiscal year.」
It states that there were no material changes in R&D activities and that R&D spending for the first quarter was ¥82 million. - FY2023Research and development expenses increased year on yearAnnual report
「The Group's R&D activities include the development of new products and technologies, the improvement and enhancement of existing products, and their application. These activities are undertaken to research and develop products that meet increasingly diverse and sophisticated user needs. Total R&D expenses for the fiscal year were ¥356 million.」
The focus and objectives of R&D were maintained, while full-year R&D expenses rose to ¥356 million from ¥337 million in FY2022. - FY2023-Q3Research and development expenses increased year on yearAnnual report
「The Group's total R&D spending for the nine-month consolidated cumulative period was ¥271 million. There were no material changes in the status of the Group's R&D activities during the nine-month consolidated cumulative period.」
There were no material changes in the R&D policy, while R&D spending rose to ¥271 million from ¥255 million in the same period of the previous year. - FY2023-Q2RestatedAnnual report
「The Group's total R&D spending for the six-month consolidated cumulative period was ¥180 million. There were no material changes in the status of the Group's R&D activities during the six-month consolidated cumulative period.」
It states that there were no material changes in R&D activities and that R&D expenses for the six-month cumulative period were ¥180 million. - FY2023-Q1R&D expenses decreased year on yearAnnual report
「Group-wide research and development expenses for the first quarter of the consolidated fiscal year were ¥82 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the consolidated fiscal year.」
There were no material changes in the R&D policy, while R&D spending fell to ¥82 million from ¥94 million in the same period of the previous year. - FY2022RestatedAnnual report
「The Group's R&D activities include the development of new products and technologies, the improvement and enhancement of existing products, and their application. These activities are undertaken to research and develop products that meet increasingly diverse and sophisticated user needs. Total R&D expenses for the fiscal year were ¥337 million.」
The R&D policy of developing new products and technologies and improving and applying existing products was maintained. Full-year R&D expenses were ¥337 million. - FY2022-Q3RestatedAnnual report
「The Group's total R&D spending for the nine-month consolidated cumulative period was ¥255 million. There were no material changes in the status of the Group's R&D activities during the nine-month consolidated cumulative period.」
There were no material changes in the R&D policy, and R&D spending for the nine-month cumulative period was ¥255 million. - FY2022-Q2RestatedAnnual report
「The Group's total R&D spending for the six-month consolidated cumulative period was ¥174 million. There were no material changes in the status of the Group's R&D activities during the six-month consolidated cumulative period.」
There were no material changes in R&D activities, and R&D spending for the second-quarter cumulative period was ¥174 million. - FY2022-Q1RestatedAnnual report
「The Group's total R&D spending for the three-month consolidated cumulative period was ¥94 million. There were no material changes in the status of the Group's R&D activities during the three-month consolidated cumulative period.」
There were no material changes in the R&D policy, and R&D spending for the first-quarter cumulative period was ¥94 million. - FY2021AdvancedAnnual report
「The Group's R&D activities include the development of new products and technologies, the improvement and enhancement of existing products, and their application. These activities are undertaken to research and develop products that meet increasingly diverse and sophisticated user needs. Total R&D expenses for the fiscal year were ¥338 million.」
The focus and objectives of R&D were maintained, while full-year R&D expenses rose to ¥338 million from ¥299 million in the previous fiscal year. - FY2021-Q3RestatedAnnual report
「The Group's total R&D spending for the nine-month consolidated cumulative period was ¥246 million. There were no material changes in the status of the Group's R&D activities during the nine-month consolidated cumulative period.」
There were no material changes in R&D activities, and R&D spending for the nine-month cumulative period was ¥246 million. - FY2021-Q2RestatedAnnual report
「The Group's total R&D spending for the six-month consolidated cumulative period was ¥165 million. There were no material changes in the status of the Group's R&D activities during the six-month consolidated cumulative period.」
There were no material changes in R&D activities, and R&D spending for the second-quarter cumulative period was ¥165 million. - FY2021-Q1RestatedAnnual report
「The Group's total R&D spending for the three-month consolidated cumulative period was ¥86 million. There were no material changes in the status of the Group's R&D activities during the three-month consolidated cumulative period.」
There were no material changes in R&D activities, and R&D spending for FY2021-Q1 was ¥86 million. - FY2020RestatedAnnual report
「The Group's R&D activities include the development of new products and technologies, the improvement and enhancement of existing products, and their application. These activities are undertaken to research and develop products that meet increasingly diverse and sophisticated user needs. Total R&D expenses for the fiscal year were ¥299 million.」
The R&D policy of developing new products and technologies and improving and applying existing products was maintained, and R&D expenses were ¥299 million. - FY2020-Q3RestatedAnnual report
「The Group's total R&D spending for the nine-month consolidated cumulative period was ¥194 million. There were no material changes in the status of the Group's R&D activities during the nine-month consolidated cumulative period.」
There were no material changes in R&D activities, and R&D expenses for the nine-month cumulative period were ¥194 million. - FY2020-Q2RestatedAnnual report
「The Group's total R&D spending for the six-month consolidated cumulative period was ¥126 million. There were no material changes in the status of the Group's R&D activities during the six-month consolidated cumulative period.」
There were no material changes in R&D activities, and R&D expenses for the second-quarter cumulative period were ¥126 million. - FY2020-Q1RestatedAnnual report
「The Group's total R&D spending for the three-month consolidated cumulative period was ¥60 million. There were no material changes in the status of the Group's R&D activities during the three-month consolidated cumulative period.」
There were no material changes in R&D activities, and R&D expenses for the first-quarter cumulative period were ¥60 million. - FY2019RestatedAnnual report
「The Group's R&D activities include the development of new products and technologies, the improvement and enhancement of existing products, and their application. These activities are undertaken to research and develop products that meet increasingly diverse and sophisticated user needs. Total R&D expenses for the fiscal year were ¥236 million.」
The R&D policy of developing new products and technologies and improving and applying existing products was maintained, and R&D expenses were ¥236 million. - FY2019-Q3RestatedAnnual report
「The Group's total R&D spending for the nine-month consolidated cumulative period was ¥159 million. There were no material changes in the status of the Group's R&D activities during the nine-month consolidated cumulative period.」
There were no material changes in R&D activities, and R&D expenses for the nine-month cumulative period were ¥159 million. - FY2019-Q1RestatedAnnual report
「Through the full-scale launch of new products, the company is developing products that meet customer needs, including products capable of serving multistory, multi-unit applications and unit-house equipment to which various functions can be added, as well as」
There were no material changes in the policy for developing products in response to new products, new technologies and customer needs, and R&D spending for the three-month cumulative period was ¥48 million. - FY2018RestatedAnnual report
「The Group's R&D activities include the development of new products and technologies, the improvement and enhancement of existing products, and their application. These activities are undertaken to research and develop products that meet increasingly diverse and sophisticated user needs. Total R&D expenses for the fiscal year were ¥220 million.」
There were no material changes in the focus or objectives of R&D, and full-year R&D expenses were ¥220 million. - FY2018-Q3RestatedAnnual report
「The Group's research and development expenses for the nine-month period ended the third quarter totaled ¥172 million. There were no material changes in the status of the Group's research and development activities during the nine-month period ended the third quarter.」
There were no material changes in R&D activities, and R&D expenses for the nine-month cumulative period were ¥172 million. - FY2018-Q2RestatedAnnual report
「The Group's research and development expenses for the six-month period ended the second quarter totaled ¥118 million. There were no material changes in the status of the Group's research and development activities during the six-month period ended the second quarter.」
There were no material changes in research and development activities, and R&D expenses for the six-month period ended the second quarter were ¥118 million. - FY2018-Q1RestatedAnnual report
「The Group's research and development expenses for the three-month period ended the first quarter totaled ¥57 million. There were no material changes in the status of the Group's research and development activities during the three-month period ended the first quarter.」
There were no material changes in research and development activities, and R&D expenses for the three-month period ended the first quarter were ¥57 million. - FY2017RestatedAnnual report
「The Group's research and development activities encompass the development of new products and technologies, the enhancement, improvement and application of existing products, and research and development of products designed to meet increasingly diverse and sophisticated user needs. Total R&D expenses for the fiscal year were ¥208 million.」
There were no material changes in the scope of research and development, which covers the development of new products and technologies and the enhancement and application of existing products, and full-year R&D expenses were ¥208 million. - FY2017-Q3RestatedAnnual report
「The group's total research and development expenditure for the cumulative third quarter of the consolidated fiscal year was ¥154 million. There were no material changes in the status of the group's research and development activities during the cumulative third quarter of the consolidated fiscal year.」
There were no material changes in research and development activities, and R&D expenses for the nine-month period ended the third quarter were ¥154 million. - FY2017-Q2RestatedAnnual report
「The Group's research and development expenses for the six-month period ended the second quarter totaled ¥99 million. There were no material changes in the status of the Group's research and development activities during the six-month period ended the second quarter.」
There were no material changes in research and development activities, and R&D expenses for the six-month period ended the second quarter were ¥99 million. - FY2017-Q1RestatedAnnual report
「The group's total R&D expenses for the cumulative three-month period were ¥48 million. There were no material changes in the status of the group's R&D activities during the cumulative three-month period.」
There were no material changes in research and development activities, and R&D expenses for the first quarter were ¥48 million. - FY2016First statedAnnual report
「The Group's research and development activities encompass the development of new products and technologies, the enhancement, improvement and application of existing products, and research and development of products designed to meet increasingly diverse and sophisticated user needs.」
To meet user needs, the scope of research and development covers new products and technologies and the enhancement and application of existing products.